NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球乾眼症候群治療藥市場(2021年-2025年)

Global Dry Eye Syndrome Drugs Market 2021-2025

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 982423
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
全球乾眼症候群治療藥市場(2021年-2025年) Global Dry Eye Syndrome Drugs Market 2021-2025
出版日期: 2021年01月12日內容資訊: 英文 120 Pages
簡介

全球乾眼症候群治療藥的市場規模在2021年∼2025年間,預測將成長到20億8000萬美元,這個期間中的年複合成長率預測將為7%。市場成長的主要因素有生活方式的變化和老年人口的增加。

本報告提供乾眼症候群治療藥市場調查,提供市場概要,市場成長要素及阻礙因素分析,各產品·各地區的市場規模的變化與預測,供應商分析,市場機會等全面性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模2020
  • 市場預測:從2020年∼2025年的預測

波特的五力分析

各產品的市場區隔

  • 市場區隔
  • 各產品比較
  • OTC藥-市場規模與預測(2020年∼2025年)
  • 處方藥-市場規模與預測(2020年∼2025年)
  • 各產品的市場機會

客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美-市場規模與預測(2020年∼2025年)
  • 歐洲-市場規模與預測(2020年∼2025年)
  • 亞洲-市場規模與預測(2020年∼2025年)
  • 其他地區-市場規模與預測(2020年∼2025年)
  • 主要國家
  • 地區的市場機會
  • 市場推動因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 創造性破壞狀況
  • 競爭模式

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • AbbVie Inc.
  • Akorn Inc.
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • Johnson & Johnson
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.

附錄

目錄
Product Code: IRTNTR46644

Technavio has been monitoring the dry eye syndrome drugs market and it is poised to grow by $ 2.08 bn during 2021-2025 progressing at a CAGR of 7% during the forecast period. Our report on dry eye syndrome drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the changing lifestyle and rising cases of diseases contributing to dry eye syndrome and growing geriatric population. In addition, changing lifestyle and rising cases of diseases contributing to dry eye syndrome is anticipated to boost the growth of the market as well.

The dry eye syndrome drugs market analysis includes product segment and geographical landscapes.

Technavio's dry eye syndrome drugs market is segmented as below:

By Product

  • OTC drugs
  • Prescription drugs

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing healthcare expenditure as one of the prime reasons driving the dry eye syndrome drugs market growth during the next few years.

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on dry eye syndrome drugs market covers the following areas:

  • Dry eye syndrome drugs market sizing
  • Dry eye syndrome drugs market forecast
  • Dry eye syndrome drugs market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dry eye syndrome drugs market vendors that include AbbVie Inc., Akorn Inc., Alcon Inc., Bausch Health Companies Inc., Johnson & Johnson, Novartis AG, Otsuka Holdings Co. Ltd., Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co. Ltd., and Sun Pharmaceutical Industries Ltd.. Also, the dry eye syndrome drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • OTC drugs - Market size and forecast 2020-2025
  • Prescription drugs - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor Landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Akorn Inc.
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • Johnson & Johnson
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: OTC drugs - Market size and forecast 2020-2025 ($ million)
  • 24: OTC drugs - Year-over-year growth 2020-2025 (%)
  • 25: Prescription drugs - Market size and forecast 2020-2025 ($ million)
  • 26: Prescription drugs - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2020-2025 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2020-2025 ($ million)
  • 32: North America - Year-over-year growth 2020-2025 (%)
  • 33: Europe - Market size and forecast 2020-2025 ($ million)
  • 34: Europe - Year-over-year growth 2020-2025 (%)
  • 35: Asia - Market size and forecast 2020-2025 ($ million)
  • 36: Asia - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ million)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: AbbVie Inc. - Overview
  • 48: AbbVie Inc. - Business segments
  • 49: AbbVie Inc. - Key offerings
  • 50: AbbVie Inc. - Key customers
  • 51: AbbVie Inc. - Segment focus
  • 52: Akorn Inc. - Overview
  • 53: Akorn Inc. - Product and service
  • 54: Akorn Inc. - Key offerings
  • 55: Akorn Inc. - Key customers
  • 56: Akorn Inc. - Segment focus
  • 57: Alcon Inc. - Overview
  • 58: Alcon Inc. - Business segments
  • 59: Alcon Inc. - Key offerings
  • 60: Alcon Inc. - Key customers
  • 61: Alcon Inc. - Segment focus
  • 62: Bausch Health Companies Inc. - Overview
  • 63: Bausch Health Companies Inc. - Business segments
  • 64: Bausch Health Companies Inc. - Key offerings
  • 65: Bausch Health Companies Inc. - Key customers
  • 66: Bausch Health Companies Inc. - Segment focus
  • 67: Johnson & Johnson - Overview
  • 68: Johnson & Johnson - Business segments
  • 69: Johnson & Johnson - Key offerings
  • 70: Johnson & Johnson - Key customers
  • 71: Johnson & Johnson - Segment focus
  • 72: Novartis AG - Overview
  • 73: Novartis AG - Business segments
  • 74: Novartis AG - Key offerings
  • 75: Novartis AG - Key customers
  • 76: Novartis AG - Segment focus
  • 77: Otsuka Holdings Co. Ltd. - Overview
  • 78: Otsuka Holdings Co. Ltd. - Business segments
  • 79: Otsuka Holdings Co. Ltd. - Key offerings
  • 80: Otsuka Holdings Co. Ltd. - Key customers
  • 81: Otsuka Holdings Co. Ltd. - Segment focus
  • 82: Prestige Consumer Healthcare Inc. - Overview
  • 83: Prestige Consumer Healthcare Inc. - Business segments
  • 84: Prestige Consumer Healthcare Inc. - Key offerings
  • 85: Prestige Consumer Healthcare Inc. - Key customers
  • 86: Prestige Consumer Healthcare Inc. - Segment focus
  • 87: Santen Pharmaceutical Co. Ltd. - Overview
  • 88: Santen Pharmaceutical Co. Ltd. - Business segments
  • 89: Santen Pharmaceutical Co. Ltd. - Key offerings
  • 90: Santen Pharmaceutical Co. Ltd. - Key customers
  • 91: Santen Pharmaceutical Co. Ltd. - Segment focus
  • 92: Sun Pharmaceutical Industries Ltd. - Overview
  • 93: Sun Pharmaceutical Industries Ltd. - Business segments
  • 94: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 95: Sun Pharmaceutical Industries Ltd. - Key customers
  • 96: Sun Pharmaceutical Industries Ltd. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations